Susan Hasty, Publisher
Table of Contents . . . December 16th, 1996Non-Subscriber - Summaries Only
Therapy (HBV) - Nucleoside Analog Fails to Enhance IFN Efficacy
Carcinogenesis (HBV) - Chromosome 8p Loss Common in HBV+ HCC Patients
Emerging Pathogens - Are All Diseases Infectious?
HIV/HCV Coinfection - HIV Contributing to HCV Infections in U.S.
Pathogenesis (HCV) - Selective Defects in Antigen-Presenting Cells Protective
Therapy (HBV) - Penciclovir (R)-Enantiomer Inhibits HBV DNA Polymerase
Therapy (TB) - Hydrazine Related to Isoniazid Liver Toxicity
Virology - Multiple Viral Inactivation in IVIg Achieved
Transplantation (HCV) - IFN/Ribavirin Combination May Prevent Graft Disease
Blood Product Safety - "Manufacturing and Downscaling Process for a Virus-Inactivated Pooled Human Plasma."
Drug Development (Antiviral) - "Phosprenyl - Antiviral Drug with Interferon-Inducing and Immunomodulatory Activities."
Immunotherapy (Infectious Diseases) - "Cytokines and Vaccines."
Pathogenesis (Hepatitis) - "Elucidating the Mode of Interferon Action Against Hepatitis B Virus in the Duck Model System."
Hepatic Complications (Chemotherapy) - "Severe Hepatitis Related to Chemotherapy in Hepatitis B Virus Carriers with Hematologic Malignancies: Survey in Japan, 1987-1991."
Transplantation (HBV) - "Lamivudine Prophylaxis Against Reinfection in Liver Transplantation for Hepatitis B Cirrhosis."
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.